Effect of Rebound Pain on Chronic Postsurgical Pain After Total Knee Arthroplasty
1 other identifier
observational
220
0 countries
N/A
Brief Summary
This prospective observational study aims to evaluate whether rebound pain after peripheral nerve block is associated with the development of chronic postsurgical pain following elective total knee arthroplasty. Adult patients undergoing unilateral total knee arthroplasty under spinal anesthesia and receiving a peripheral nerve block as part of routine multimodal analgesia will be included. No additional intervention, drug administration, or biological sampling will be performed beyond standard clinical care. Rebound pain will be assessed during the early postoperative period using pain diaries, numeric rating scale pain scores, and analgesic consumption records. Chronic postsurgical pain and related outcomes will be evaluated at postoperative 3 and 6 months using validated instruments assessing pain severity, neuropathic pain features, psychological status, functional outcomes, and health-related quality of life. The primary outcome is the presence of chronic postsurgical pain at 3 months after surgery. Secondary outcomes include chronic pain at 6 months, pain intensity, neuropathic pain characteristics, opioid consumption, rescue analgesic requirements, sleep disturbance, and quality-of-life measures. The study also aims to explore demographic and clinical factors associated with rebound pain and chronic postsurgical pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2026
CompletedFirst Posted
Study publicly available on registry
April 6, 2026
CompletedStudy Start
First participant enrolled
April 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 12, 2026
April 9, 2026
April 1, 2026
8 months
March 30, 2026
April 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of Chronic Postsurgical Pain at 3 Months
Chronic postsurgical pain will be defined as pain developing or persisting after total knee arthroplasty that is not explained by another cause. Participants with pain and at least one Brief Pain Inventory-Short Form interference item score of 3 or higher at postoperative month 3 will be considered positive for chronic postsurgical pain.
3 months after surgery
Secondary Outcomes (2)
Presence of Chronic Postsurgical Pain at 6 Months assessed by Brief Pain Inventory-Short Form (BPI-SF) interference score
6 months after surgery
Pain Intensity in the Early Postoperative Period
0 to 72 hours after surgery
Study Arms (2)
Rebound Pain
Participants with a transition from well-controlled pain (Numeric Rating Scale \[NRS\] \<=3) to severe pain (NRS \>=7) within 0 to 48 hours after peripheral nerve block resolution.
No Rebound Pain
Participants without a transition from well-controlled pain (Numeric Rating Scale \[NRS\] \<=3) to severe pain (NRS \>=7) within 0 to 48 hours after peripheral nerve block resolution.
Eligibility Criteria
Adult patients undergoing unilateral elective total knee arthroplasty at Konya City Hospital under spinal anesthesia and receiving a peripheral nerve block as part of routine multimodal analgesia.
You may qualify if:
- Age 18 years or older
- ASA physical status I to III
- Scheduled for unilateral elective total knee arthroplasty
- Planned to undergo spinal anesthesia
- Planned to receive a peripheral nerve block as part of routine multimodal analgesia
- Able to provide informed consent and complete study assessments
You may not qualify if:
- Chronic opioid use (60 mg oral morphine equivalent per day or more, or use for 3 months or longer)
- Significant neuropathy or radiculopathy
- Bilateral or two-stage total knee arthroplasty during the same hospitalization
- Contralateral total knee arthroplasty within the previous 6 months
- Severe cognitive impairment or major psychiatric disorder
- Chronic analgesic dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmut Tutar, MD
KONYA CITY HOSPİTAL
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Anesthesiology and Reanimation
Study Record Dates
First Submitted
March 30, 2026
First Posted
April 6, 2026
Study Start
April 7, 2026
Primary Completion (Estimated)
December 12, 2026
Study Completion (Estimated)
December 12, 2026
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share